Moore; Keith P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moore; Keith P..The latest application filed is for "pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles".

Company Profile

0.13.16

Moore; Keith P. - Doylestown PA
Moore; Keith P. - Bensalem PA
Moore; Keith P. - Harleysville PA US
Moore; Keith P. - North Wales PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles Grant 10,022,461 - Walji , et al. July 17, 2	2018-07-17
Pyrrolo[2,3-c]pyridines As Imaging Agents For Neurofibrilary Tangles App 20180071412 - Walji; Abbas M. ; et al.	2018-03-15
TRKA kinase inhibitors, compositions and methods thereof Grant 9,862,716 - Mitchell , et al. January 9, 2	2018-01-09
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary Grant 9,808,542 - Walji , et al. November 7, 2	2017-11-07
Pyrrolo[2,3-c]pyridines As Imaging Agents For Neurofibrillary App 20170119912 - Walji; Abbas W. ; et al.	2017-05-04
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114056 - Mitchell; Helen ; et al.	2017-04-27
Oxazole derivatives useful as modulators of FAAH Grant 9,193,697 - Yang , et al. November 24, 2	2015-11-24
2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease Grant 8,492,387 - Hills , et al. July 23, 2	2013-07-23
Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease Grant 8,399,473 - Nantermet , et al. March 19, 2	2013-03-19
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Grant 8,394,837 - Nantermet , et al. March 12, 2	2013-03-12
Aza-indole Derivatives Useful As Modulators Of Faah App 20130059850 - Walji; Abbas M ; et al.	2013-03-07
Oxazole Derivatives Useful As Modulators Of Faah App 20130018048 - Yang; ZhiQiang ; et al.	2013-01-17
Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's disease Grant 7,951,949 - Nantermet , et al. May 31, 2	2011-05-31
2-aminoimidazole Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease App 20110034483 - Hills; Ivory D. ; et al.	2011-02-10
Epha4 Rtk Inhibitors For Treatment Of Neurological And Neurodegenerative Disorders And Cancer App 20100113415 - Rajapakse; Hemaka A. ; et al.	2010-05-06
Hiv Protease Inhibitors App 20100093811 - Coburn; Craig A. ; et al.	2010-04-15
Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease Grant 7,678,783 - Nantermet , et al. March 16, 2	2010-03-16
Macrocyclic Spiropiperidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease App 20100029701 - Nantermet; Philippe G. ; et al.	2010-02-04
Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease App 20080269302 - Nantermet; Philippe G. ; et al.	2008-10-30
Macrocyclic Aminopyridyl Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease App 20080015213 - Nantermet; Philippe G. ; et al.	2008-01-17
2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease App 20070293497 - Nantermet; Philippe G. ; et al.	2007-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.